Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Operating Expenses | 4,913 | 6,354 | 5,207 | 6,695 | 7,203 |
| Operating Income | -4,913 | -6,354 | -5,207 | -6,695 | -7,203 |
| Other Income | 50 | 30 | 44 | 372 | 150 |
| Pre-tax Income | -4,863 | -6,323 | -5,163 | -6,323 | -7,054 |
| Net Income Continuous | -4,863 | -6,323 | -5,163 | -6,323 | -7,054 |
| Net Income | $-4,863 | $-6,323 | $-5,163 | $-6,323 | $-7,054 |
| EPS Basic Total Ops | -1.20 | -2.10 | -1.50 | -2.70 | -3.60 |
| EPS Basic Continuous Ops | -1.32 | -2.15 | -1.38 | -2.62 | -3.64 |
| EPS Diluted Total Ops | -1.20 | -2.10 | -1.50 | -2.70 | -3.60 |
| EPS Diluted Continuous Ops | -1.32 | -2.15 | -1.38 | -2.62 | -3.64 |
| EBITDA(a) | $-4,900 | $-6,342 | $-5,197 | $-6,684 | $-7,189 |